Skip to content
← Myeloproliferative Neoplasms

FOR PATIENTS · SOURCE READING

Immunotherapy

Source: Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 12, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Option Overview / The following types of treatment are used:

Immunotherapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer.

Source links and citations

Interferon: Interferon affects the division of cancer cells and can slow tumor growth. Interferon alfa and pegylated interferon alpha are commonly used to treat certain myeloproliferative neoplasms.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice